(1)...3 (2)...5 (3)...6 (4) (1)...9 (2)...10 (3)...13 (4) 14 (5) (1)...16 (2) (1)...21 (2)...22 (3)

Similar documents
Microsoft Word 年度DPCによるSPECT検査動向に関する報告 _02表紙.doc

,

science

untitled

天草郡市医師会第139回(臨時)代議員会

26 multiculturarism 25 EU 21

untitled

1 発病のとき


3.....ren

2015電磁波_歯科医.rtfd

第4章 ポーランド

次世代育成支援行動計画

86 7 I ( 13 ) II ( )



1章

53

4 A) (OECD,2005) (WHO,2002) B) 5 A) B) C) 1 7 2

untitled

がん診療におけるFDG FDG-PET/CTの役割

PISA

2


サポートブック



第2巻/1-5



DAC A DAC DAC OECD ( 192 )

資料・医療制度改革をめぐる論点

REPORT



untitled


, ,

原田 泰5‐34/5‐34

中期経営計画 「NEXTAGE‐05」説明会

1

untitled

発達障害_表01

X FCR Fuji Computed Radiography FCR CR Computed Radiography 2009 CR X X CR CR GE CR 1980 CR 6 CR CR CR FCR FCR FCR X X 1895 X X X

平成14年度 湘南市の将来都市像研究報告



- - i

untitled


29




喀痰吸引

平成18年度「商品先物取引に関する実態調査」報告書


スライド 1

[ 708 ] , EU 48 OECD OECD

Vol. 47, No. 1, January 2001

10Disclosure_H0104_0618

untitled



net-h12_12.doc

(資料2)第7回資料その1(ヒアリング概要)



<4D F736F F D DEC8BC A95BD90AC E A982BA81698AB A B B4790DF90AB8EBE8AB FC89408A4F816A82CC93AE8CFC82C98AD682B782E9838C837C815B D

, , ,210 9, ,

B B B B B B

Microsoft Word - MedicalMonthlyREPORT2011年10月

2

橡SP01.pdf

: Voice V 2009 GDP 02% OECD 3 LG FTA EU FTA TPP 2010a b ? Focus

,195, ,025, ,634, ( )


飯能市と名栗村の新しいまちづくり計画に関する住民意識調査

第59期事業のご報告

NIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml

>Tokyo Dome Group Business Report 2010:

義務教育費国庫負担制度について

20●12頁●6-14▲放射線科▲.ppt

医療機器指令 93/42/EEC の概要(第2版)



,829 [ 633 ] , EU 48 OECD OECD

SBSGroup_CSR_h01-h04_0820CS5.ai

untitled

韓国の教育自治

44-1(前11)7回春季大会


03_学術.indd

1

1

CRC CRC CRC No F TEL : FAX : URL :

untitled

橡kaikei_QA_2001_05_11.PDF

- 1 -


Transcription:

...1...3...3 (1)...3 (2)...5 (3)...6 (4)...7...9 (1)...9 (2)...10 (3)...13 (4) 14 (5)...15...16 (1)...16 (2)...19...21 (1)...21 (2)...22 (3)...24...26...26 (1)...26 (2)...28 (3)...30 (4)...31 (5)...35 (6)...38 (7)...40...43 (1)...43 (2)...44 (3)...45...46 (1)...46 (2)...47 (3)...52...54 (1)...54 (2)...56...60...63...63 (1)...63 (2)...64 (3)...69 (4)...70 (5)...76...77 (1)...79 (2)...82 (3)...84 (4)...85 (5)...87...88...90...90 (1)...90 (2) OEM..91 (3)...92 (4)...92 (5)...93 (6)...94...95..98...98...99 (1)...99 (2)...105 (3)...112 (4)...118 (5)...126 (6)...128 (7)...133 (8)...134 (9)...137..138 (1)...138 (2)...140 (3)...140 (4)...141 (5)...142 (6)...143...146...149...167

1

2

2000 1.91 2001 1.89 1990 1.26 10 2 7.2 1.4 2.0 2.4 2.8 2002 7 12 1.5 2001 1 2000 2002 1.8 2000 2001 3

42 26 15 8 36 19 10 65 2000 Eucomed EU EU GDP 5.7 13.9 7.1 66 125 116 Medical Devices Experts Group, Report On The Functioning of The Medical Devices Directive: Final report 05-06-2002 corr 1. EU 4

2000 30.4 7.98 1.89 6 1984 15 16 2000 30 1999 2000 2000 GDP 1990 1980 1979 1994 6 1999 8.1 2000 7.98 8 2001 1.89 1984 9,200 2.2 1984 =100 5

1960 1970 1990 1961 1960 1970 1960 1980 6

7 1990 1990 1999 65 10 3,909 3564 337 17 2010 23 2020 28

1990 20.6 30.4 4.0 OECD 2000 GDP 13.0 10.7 10.6 9.5 7.8 OECD 8.0 2010 2.32.8 2000 1.9 8

10 9

10 1980 2000 30.5 16.1 14.9 10.0 4.5 6.1 6.4 27 2000

11 1986 1999 1970 80 90 95 2000 0.0 1.4 2.6 4.7 9.2 1988 1985 1988 1

1980 1990 1990 1990 1990 1960 1970 1980 1990 1990 1970 1961 1980 1980 (2) 12

) 1980 1990 120 50 60 1993 30 14 17 14 (2)(3) ) 20 5 13

MRI CT 63 4 6 15 2 14

15 1951 1958 1971 1987 1998

16 1999 2001 1.89 117,309 1,614 29.4 24.6 20.3

25.6 2001 100 3,843 20.3% 3,589 19.0 2,712 14.3 1,454 7.7 17

18

1,051 5.6% 176 0.9% 300 100200 64.2 1990 1.26 2001 1.89 10 6,300 50 1999 1988 1998 10 19

20 1988 1998

1950 1951 1950 1960 70 1958 1962 1950 1960 1960 1970 1980 1972 EMI CT 1978 MRI CT MRI PET CT MRI 5 (*) 1985 1995 1995 2001 2002 21

1940 50 '50 '51 '58 ME 1960 '62 70 '72 CT 1970 '74 PTCA 80 '78 MRI 1980 '85 87 90 IVR PET ESWL DDS 2001 IVR DDS 22

1970 1.7 3.5 1990 IVR 1929 1953 1964 IVR PTA 1974 PTCA 1985 2002 1950 23

1957 1968 1987 1990 40 10 IVR 24

25 a) b) c)dds d) e) f) g) h) i) QOL 2001 DDS

2000 2,576 53,338 1 4,358 1997 5,388 300,138 548 120 6 5,760 2.1 5.6 4.6 5 4.5 6.4 25.5 12.9 2.2 29.8 26

27

1995 2000 2,286 2,349 1,169 1,218 96,604 90,176 2000 2,349 2,576 3 37.8 49 32.7 200 42 1.6 4 33.6 59 17.4 250 5.4 EU medical technology business entities 50 70 250 94 Eucomed 28

29

2000 1,580 1,487 93 1,020 259 301 56 2 1.6 5 30

Medical Device & Diagnostic Industry 40 19 25 31

CT 32

1 () X CT MRI 2 ()MRI CT X X TV 3 () CT X TV 4 () X X X X II X TV X X X X ECT CT 5 () X X X 6 X CT X / C () IT MR 7 X CT MRI () X 8 X X CT () X TV X X ECT CT 9 COMPUTED RADIOGRAPHYCR X () 10 () 11 () 12 () 13 () 14 () 15 () 16 () 17 () 18 () 19 () 20 () 33

21 () 22 () 23 () 24 () 25 () 26 () 27 () 28 () 29 () 30 () 31 () 32 () 33 () 34 () 35 () 36 () 37 () 38 () 39 () 40 () 41 () 42 () 43 () 44 () CT 45 () 46 () 47 () 48 () 49 () 50 () 2000 34

5000 1,006 63.7 35

36 2000 2000

2000 37

22.2 10 2 500 10 3 1 1.5 2000 3.79 4.04 50 50 38

19971999 (4) 39

40

41

42

2001 1 8,932 8,363 44.2 1985 2122 15 1990 2001 1 5,170 3,975 26.2 15 2025 1990 43

32 105 49 1999 44

10 774 872 1990 1990 5,273 63.1 6 1,790 21.4 859 10.3 5 2001 45

15 2 4 46

47 (*) 2000

48

49

1,700 1,000 90 IVR 42 1992 1.000 100 50

95 MRI 1980 90 90 1970 51

(3) 52

53

54 12.1 19.122.4 29.4 12.5

12.1 22.4 29.4 19.1 1997 33.8 39.8 21.8 6.8 9.8 5,712 2,894 50.7 2,762 48.4 55

PTCA (*) (**) 1985 1990 (*) 11 (**) 14 8 56

1980 1990 1990 57

58

59 4 4 1997 4 3 5 2002 4 1.3

12 1.5 0.3 0.8 6 8 1.35 ODA 60

(a) BECON (b) (c) NIH 12 4 BECON (*) METIS (*) Bioengineering Consortium 1997 NIH 61

62

63 1) 2) 3) 4) 5) 6) GMP 7) 8)

64 9) 10) PL PL 11) 12) 3) 9) 2) 10) 11) 12) 14

MRI GCP GMP GPMSP GCP GMP GPMSP 65

1 34 1.0 3 0.5 0.1 2.0 *1 5 1.01.5 0.2 PTCA 1.0 0.5 1 *1 14 8 2 FDA 2002 4 66

12 GMP GPMSP 67

68

1994 2001 1992 FDA 1998 BAA 69

70 GDP 8 30 10 14 5,500 35

71 10 250 270 59 74 70 25 14 1,668 1,216452 20 155 20 200 10 7 716 493+223 650 3,800 8,000 28 32 3,600 1,140 85 148 1,660 9 6 81 155 1,400 660 660 390 340 392 1,630 9,600 7,470 63,700 20,500 19,900 500 800 2 5,930 110 1,920 14

1.3 1.4 2.7 25 21 20 17 180 85 15 18 110 70 18 FDG 7,500 655 620 1,660 1,140 (2)) 14 14 1,490,000 263,000 338,000 14 4.112.31 1,420,000 239,000 331,000 15 1.112.31 1,360,000 218,000 328,000 1,310,000 213,000 324,000 5 9 24 72

C2 73

74,700 74

GDP 10 1983 (*) (**) 1989 14 25 21 14 (*) Diagnosis Related Group / Prospective Payment System 500 DRG (**) DRG/PPS 9.6 7.4 2 2000 75

1991 76

24 77

No 1 19 3,000 2 108 3 200 No 4 1975 300499 5 1871 300499 6 1948 1,000 7 1965 1,000 8 1976 1029 9 1984 1029 10 G 1999 1029 11 1992 3049 12 1986 1029 No 13 1976 10 14 I 1960 5099 1996 15 1969 10 1980 16 1939 500999 1995 1999 17 1953 300499 1994 18 1970 1029 1994 No 19 2000 1029 3PL 20 1947 1029 21 1996 100299 No 22 200300 PTCA 750 23 24 78

(5) QOL 79

TLO 80

81

10 34 45 82

2 2 4 2 6 1 OEM 83

M&A 100 84

100 10 1 3)5) 1 3) 5) 1) 1 2) 1 3) OEM 4 4) 1 5) 4 6) 1 5) 5) 6) 1)2) 85

86 1 OEM 1 1

2 1 30 87

1) 2) 3) 4)PL FDA 88

14 8 89

OEM (4) 2002 9 10 3 90

OEM OEM OEM OEM OEM 91

92

93

94

1 6,500 5 7 2002 4 18 OEM 1999 11 50 400 1 95

1970 45 28 2,000 6 2 2001 1986 61 2 96

2 122 4 5 2001 27 (4) (1) 97